NovoCure Ltd — Director's Dealing 2022

Mar 11, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2022-03-03

Reporting Person: Cordova Ashley (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-03	Ordinary Shares	M	3840	$15.60	Acquired	64688	Direct
2022-03-03	Ordinary Shares	M	1200	$11.46	Acquired	65888	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-03	Options to Buy Ordinary Shares	$15.6	M	3840	Disposed	2025-04-22	Ordinary Shares (3840.0)	Direct
2022-03-03	Options to Buy Ordinary Shares	$11.46	M	1200	Disposed	2026-02-24	Ordinary Shares (1200.0)	Direct

Footnotes

F1: Fully vested as of the date hereof.